Late complications after radiotherapy for prostate cancer H. JungH.-P. Beck-BornholdtT. Herrmann Original article 11 October 2012 Pages: 965 - 974
Anti-inflammatory effects of low-dose radiotherapy M. ArenasS. SabaterJ. Panés Review article 22 August 2012 Pages: 975 - 981
Toxicity and outcome of pelvic IMRT for node-positive prostate cancer A.-C. MüllerJ. LütjensU. Ganswindt Original article 11 October 2012 Pages: 982 - 989
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer F. AlongiA. FogliataM. Scorsetti Original article 29 September 2012 Pages: 990 - 996
Erectile dysfunction after prostate three-dimensional conformal radiation therapy A. MagliM. GiangrecoS. Fongione Original article 29 September 2012 Pages: 997 - 1002
Adaptive off-line protocol for prostate external radiotherapy with cone beam computer tomography M. PiziorskaP. KukołowiczP. Pęczkowski Original article 10 October 2012 Pages: 1003 - 1009
Radiation-induced morphological changes in the vagina K. KirchheinerE. FidarovaW. Dörr Original article 29 September 2012 Pages: 1010 - 1019
Large mediastinal tumor mass as a prognostic factor in Hodgkin’s lymphoma J. KrizR.-P. MuellerH.T. Eich Original article 10 October 2012 Pages: 1020 - 1024
Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin’s lymphoma C. Lütgendorf-CaucigI. FotinaEuroNet-PHL RT Group Original article 10 October 2012 Pages: 1025 - 1030
Prognostic value of HIF-1α expression during fractionated irradiation L. HelbigA. YarominaD. Zips Original article 29 September 2012 Pages: 1031 - 1037
Survivin, a target to modulate the radiosensitivity of Ewing’s sarcoma B. GreveF. Sheikh-MounessiH.T. Eich Original article 10 October 2012 Pages: 1038 - 1047
Metastatic spinal cord compression in patients with cancer of unknown primary S. DouglasS.E. SchildD. Rades Short communication 29 September 2012 Pages: 1048 - 1051
Aktualisierung der SWOG-Intergroup-Studie 0116: Trotz eindrücklicher Ergebnisse ist die adjuvante Radiochemotherapie des Magenkarzinoms nach RO-Resektion noch kein Standard T. Brunner Literatur kommentiert 29 September 2012 Pages: 1052 - 1053
Lokalisation von Koronarstenosen nach Strahlentherapie wegen Mammakarzinom F. LohrF. Heggemann Literatur kommentiert 29 September 2012 Pages: 1054 - 1056
Zusammenhang zwischen BRCA1- und BRCA2-Mutationen mit dem Überleben von Patientinnen mit invasivem epithelialem Ovarialkarzinom (EOC) M. Bremer Literatur kommentiert 10 October 2012 Pages: 1057 - 1058
Professor Dr. med. Michael Bamberg zum 65. Geburtstag W. Budach Laudatio 03 October 2012 Pages: 1059 - 1060